Image

Intraoperative Methadone for the Prevention of Postoperative Pain

Recruiting
18 - 80 years of age
Both
Phase 3

Powered by AI

Overview

The pain felt after orthopedic surgery in the absence of adequate locoregional anesthesia is often insufficiently controlled, especially during the first 24 hours postoperatively.

Methadone, due to its long half-life, may provide better pain control after orthopedic surgery when associated locoregional anesthesia cannot be performed.

It may be impossible to perform loco-regional anesthesia in various contexts: patient refusal, pre-existing neurological impairment, infection at the injection site, coagulopathies, inability to cooperate, total language barrier, allergy to anesthetics, unavailability of equipment (ultrasound, etc.) or equipped room, lack of experience of nursing staff in performing the block and in the postoperative management of the patient.

Intraoperative administration of methadone in these settings may be superior to sufentanil for pain control during the 24 hours post orthopedic surgery, and the pain control provided by methadone does not appear to imply a higher likelihood of adverse events related to opioids.

Eligibility

Inclusion Criteria:

  • Age between 18 and 80 years old
  • ASA 1-3 status
  • Elective partial or total hip and knee arthroplasty

Exclusion Criteria:

  • Patient refusal
  • Preoperative renal failure (serum creatinine > 2 mg/dL or 1.5-fold
  • Increase in basal plasma creatinine or GFR < 90 ml/min/1.73m2)
  • Significant hepatic dysfunction (PT <50% or increase in 3 times basal transaminases)
  • Known heart failure
  • Preoperative hemodynamic instability (preoperative use of inotropes or vasopressors)
  • Known methadone or sufentanil allergy
  • Preoperative opioid use or history of opioid abuse
  • Pregnancy and breastfeeding.

Study details

Orthopedic Surgery

NCT05831345

Brugmann University Hospital

31 March 2025

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.